Selected article for: "ART antiretroviral therapy and high risk"
Author: Andrew Clark; Mark Jit; Charlotte Warren-Gash; Bruce Guthrie; Harry HX Wang; Stewart W Mercer; Colin Sanderson; Martin McKee; Christopher Troeger; Kanyin I Ong; Francesco Checchi; Pablo Perel; Sarah Joseph; Hamish P Gibbs; Amitava Banerjee; Rosalind M Eggo
Title: How many are at increased risk of severe COVID-19 disease? Rapid global, regional and national estimates for 2020
  • Document date: 2020_4_22
    • ID: czuq8rw5_23
    Snippet: Asthma is relatively common, and mild asthma is not listed as a high risk group for shielding so we modified GBD estimates of asthma to account only for moderate-to-severe cases (defined as British Thoracic Society Steps 4, 5 and 6). 14 Based on published evidence from the UK we assumed these were 15% of total asthma cases aged <5 years, 17% aged 5-19 years, 23% aged 20-54 years, and 43% in those aged 55+ years. 15 For HIV/AIDS, we included all p.....
    Document: Asthma is relatively common, and mild asthma is not listed as a high risk group for shielding so we modified GBD estimates of asthma to account only for moderate-to-severe cases (defined as British Thoracic Society Steps 4, 5 and 6). 14 Based on published evidence from the UK we assumed these were 15% of total asthma cases aged <5 years, 17% aged 5-19 years, 23% aged 20-54 years, and 43% in those aged 55+ years. 15 For HIV/AIDS, we included all populations, including those on ART. However, we carried out a sensitivity analysis to determine how estimates would change if we removed individuals using antiretroviral therapy (ART) for instance if there is found to be no additional risk of HIV in individuals on ART. We used WHO national estimates for ART coverage among those living with HIV/AIDS. 16

    Search related documents:
    Co phrase search for related documents
    • additional risk and ART antiretroviral therapy: 1
    • additional risk and high risk group: 1, 2, 3, 4, 5
    • additional risk and HIV additional risk: 1, 2, 3
    • antiretroviral therapy and ART antiretroviral therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiretroviral therapy and art coverage: 1, 2, 3
    • antiretroviral therapy and ART include: 1, 2, 3
    • antiretroviral therapy and ART individual: 1, 2
    • antiretroviral therapy and HIV additional risk: 1
    • asthma case and high risk group: 1
    • asthma case and mild asthma: 1, 2, 3, 4, 5, 6, 7